Finecure Pharmaceuticals Limited is leading manufacturers and marketers of Pharmaceutical formulations in several therapeutic segments in dosage forms of Oral Tablets, Capsules,Liquids,Dry Syrup, Powders and Injections. Finecure has modern facilities, skills and resources that are at par with the best in the country. The company is certified for WHO GMP, ISO 9001, ISO 22001, ISO 14001, OHSAS 18001 quality systems towards High Product Quality Assurance, Environment Management System, Occupational Health and safety. The Company is CRISIL 1A rated towards "Highest Performance Capability" and "High Financial Strength". Finecure runs on principles of quality management systems as per EFQM guided by its mission, vision, values and ethics which act as role models. Finecure has shown an annual growth of 43% (CAGR) in the last three fiscal year indicating company's strategic policy implementation and performance strength. The company continues to explore avenues of growth and development through SBU's focusing on the Domestic and Export Markets. Backed by a determined administration, a resolute workforce, state-of-the-art work environment, an effective R&D and F&D department, the company is poised to take significant strides towards further progress and accomplishment. Finecure has several accolades to its credit including the “Arch of Europe Award 2012”,“Assocham India Business Excellence Award 2013” , “Asia's Most Promising Brand 2014” , “Healthcare and Pharmaceutical Award, UK 2015”, “IPE Fastest growing Pharma Company Award 2015”, Ranked 38th in “Dream Companies to Work for , Times Ascent World HRD Congress 2016”, “Assocham India Pharma company of the Year 2016” in Operational excellence and “Assocham India Leadership Award 2016”, as the Most Promising and Trusted Brands in Pharmaceutical Industries of the Year 2016.